| 1 | 1352739-17-3 | (Ra,R,R)-7,7′-bis(4′-phenyloxazol-2-yl)-1,1′-spirobiindane | (Ra,R,R)-7,7′-bis(4′-phenyloxazol-2-yl)-1,1′-spirobiindane | C35H30N2O2
| | |
| 2 | | N-{3-[(diphenylacetyl)amino]-4-methylphenyl}-2,2-diphenylacetamide | N-{3-[(diphenylacetyl)amino]-4-methylphenyl}-2,2-diphenylacetamide | C35H30N2O2
| | |
| 3 | 365542-46-7 | 4-[2-[4-[2-methoxy-5-[2-(4-quinolyl)ethyl]phenoxy]phenyl]ethyl]quinoline | 4-[2-[4-[2-methoxy-5-[2-(4-quinolyl)ethyl]phenoxy]phenyl]ethyl]quinoline | C35H30N2O2
| | |
| 4 | 67437-14-3 | 4,4'-[3-[2,2-Bis(4-methoxyphenyl)vinyl]-2,2-dimethylcyclopropane-1,1-diyl]bisbenzonitrile | 4,4'-[3-[2,2-Bis(4-methoxyphenyl)vinyl]-2,2-dimethylcyclopropane-1,1-diyl]bisbenzonitrile | C35H30N2O2
| | |
| 5 | 394738-76-2 | (3aR,3a'R,8aS,8a'S)-2,2'-(1,3-二苯基丙烷-2,2-二基)双(3a,8a-二氢-8H-茚并[1,2-d]噁唑) | (3aR,3a'R,8aS,8a'S)-2,2'-(1,3-diphenylpropane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole) | C35H30N2O2
| | |
| 6 | 890090-21-8 | (R)双[(4S)-(苯基)恶唑-2-基)]-7,7,-2,2,3,3-四氢-1,1,6,6'-二醇 | (R)-7,7Bis[(4S)-(phenyl)oxazol-2-yl)]-2,23,3tetrahydro-1,1spirobiindane, min. 97% (Ra,S,S)-SpiroBOX | C35H30N2O2
| | |
| 7 | 2101474-76-2 | 8H-Indeno[1,2-d]oxazole, 2,2'-[2-phenyl-1-(phenylmethyl)ethylidene]bis[3a,8a-dihydro-, (3aR,3'aR,8aS,8'aS)-rel- | 8H-Indeno[1,2-d]oxazole, 2,2'-[2-phenyl-1-(phenylmethyl)ethylidene]bis[3a,8a-dihydro-, (3aR,3'aR,8aS,8'aS)-rel- | C35H30N2O2
| | |
| 8 | 1224886-00-3 | | (3Z)-N-(1,1-Dimethylethyl)-3-(1,3-diphenyl-2-propyn-1-ylidene)-2,3-dihydro-2-oxo-α-phenyl-1H-indole-1-acetamide | C35H30N2O2
| | |